- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Advanced Thyroid Cancer Controversy and Consensus ; volume:41 ; number:04 ; year:2020 ; pages:476-480
Indian journal of medical & paediatric oncology ; 41, Heft 04 (2020), 476-480
- Beteiligte Personen und Organisationen
-
Rao, Karthik
Deshmukh, Anuja
Pai, Prathamesh
Pantvaidya, Gouri
- DOI
-
10.4103/ijmpo.ijmpo_145_20
- URN
-
urn:nbn:de:101:1-2021082715121900428021
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rao, Karthik
- Deshmukh, Anuja
- Pai, Prathamesh
- Pantvaidya, Gouri
Ähnliche Objekte (12)
The case-control study consensus and controversy
Controversy and consensus: nuclear beta decay 1911 - 1934
Energy Transition in Japan: From Consensus to Controversy
Energy Transition in Japan: From Consensus to Controversy
Treatment of advanced thyroid cancer refractory to therapy
Renal replacement therapy in acute kidney injury: controversy and consensus
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Controversy
Controversy
Advanced Breast Cancer : AGO Recommendations 2022 – Focus on ABC6 Consensus
Thyroid cancer
The case-control study consensus and controversy
Controversy and consensus: nuclear beta decay 1911 - 1934
Energy Transition in Japan: From Consensus to Controversy
Energy Transition in Japan: From Consensus to Controversy
Treatment of advanced thyroid cancer refractory to therapy
Renal replacement therapy in acute kidney injury: controversy and consensus
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Controversy
Controversy
Advanced Breast Cancer : AGO Recommendations 2022 – Focus on ABC6 Consensus
Thyroid cancer
The case-control study consensus and controversy
Controversy and consensus: nuclear beta decay 1911 - 1934
Energy Transition in Japan: From Consensus to Controversy
Energy Transition in Japan: From Consensus to Controversy
Treatment of advanced thyroid cancer refractory to therapy
Renal replacement therapy in acute kidney injury: controversy and consensus
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Controversy
Controversy
Advanced Breast Cancer : AGO Recommendations 2022 – Focus on ABC6 Consensus